Specificity for lymph node metastasis was 98% (95% CI, 94%-100%) and 100% (95% CI, 96%-100%) for PSMA PET and MRI, respectively (eTable 3 in Supplement 1). The gene discussed is FOLH1; the disease is metastatic malignant neoplasm in the lymph nodes.